HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >

Sort by: In order: Results/Page Authors/Record:
Export metadata:
Showing results 1 to 9 of 9
TypeAuthor(s)TitleOther TitlesCitationCitation(alt)Issue Date
article (author version)Miya, Aika; Nakamura, Akinobu; Yokota, Isao; Cho, Kyu Yong; Kameda, Hiraku; Nomoto, Hiroshi; Takase, Takahiro; Omori, Kazuno; Ono, Mayuko; Nagai, So; Taneda, Shinji; Miyoshi, Hideaki; Atsumi, TatsuyaThe agreement between measured HbA1c and optimized target HbA1c based on the Dementia Assessment Sheet for Community-based Integrated Care System 8-items (DASC-8) : A cross-sectional study of elderly patients with diabetes-Geriatrics & gerontology international-Aug-2022
articleOba-Yamamoto, Chiho; Kameda, Hiraku; Miyoshi, Hideaki; Sekizaki, Tomonori; Takase, Takahiro; Yanagimachi, Tsuyoshi; Fujita, Yukihiro; Nomoto, Hiroshi; Cho, Kyu Yong; Nakamura, Akinobu; Nagai, So; Atsumi, TatsuyaAcromegaly Cases Exhibiting Increased Growth Hormone Levels during Oral Glucose Loading with Preadministration of Dipeptidyl Peptidase-4 Inhibitor-Internal medicine-1-Aug-2021
articleMiyoshi, Arina; Kameda, Hiraku; Nagai, So; Nakamura, Akinobu; Miya, Aika; Takase, Takahiro; Atsumi, Tatsuya; Miyoshi, HideakiBeneficial effects of switching to denosumab from bisphosphonates or selective estrogen receptor modulators in postmenopausal women with type 2 diabetes and osteopenia/osteoporosis-Journal of Diabetes Investigation-8-Jul-2021
articleCho, Kyu Yong; Nakamura, Akinobu; Omori, Kazuno; Takase, Takahiro; Miya, Aika; Yamamoto, Kohei; Nomoto, Hiroshi; Kameda, Hiraku; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiFavorable effect of sodium–glucose cotransporter 2 inhibitor, dapagliflozin, on non‐alcoholic fatty liver disease compared with pioglitazone-Journal of Diabetes Investigation-8-Jul-2021
articleTakase, Takahiro; Nakamura, Akinobu; Yamamoto, Chiho; Nomoto, Hiroshi; Miya, Aika; Dannoura, Midori; Cho, Kyu Yong; Kurihara, Yoshio; Manda, Naoki; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiImprovement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes : A randomized controlled trial-Journal of Diabetes Investigation-May-2019
articleOmori, Kazuno; Nomoto, Hiroshi; Nakamura, Akinobu; Takase, Takahiro; Cho, Kyu Yong; Ono, Kota; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiReduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide : A randomized controlled trial of repaglinide vs sulfonylurea-Journal of Diabetes Investigation-Mar-2019
articleCho, Kyu Yong; Nakamura, Akinobu; Omori, Kazuno; Takase, Takahiro; Miya, Aika; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiEffect of switching from pioglitazone to the sodium glucose co-transporter-2 inhibitor dapagliflozin on body weight and metabolism-related factors in patients with type 2 diabetes mellitus : An open-label, prospective, randomized, parallel-group comparison trial-Diabetes, Obesity and Metabolism-Mar-2019
articleYamauchi, Yuki; Nakamura, Akinobu; Takahashi, Kiyohiko; Takase, Takahiro; Yamamoto, Chiho; Yokota, Isao; Atsumi, Tatsuya; Miyoshi, HideakiFactors with remission of fatty liver in patients With type 2 diabetes treated with ipragliflozin-Endocrine journal-2019
articleTakase, Takahiro; Nakamura, Akinobu; Miyoshi, Hideaki; Yamamoto, Chiho; Atsumi, TatsuyaAmelioration of fatty liver index in patients with type 2 diabetes on ipragliflozin : an association with glucose-lowering effects-Endocrine Journal-Mar-2017
Showing results 1 to 9 of 9

 

Hokkaido University